Muscle-Specific Multimodal AI for Sarcopenia Diagnosis

ConditionSarcopenia
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age65-85
SponsorSeoul National University Bundang Hospital

About this trial

This study aims to develop a muscle-specific multimodal artificial intelligence (AI) model for the diagnosis of sarcopenia and to investigate the effects of rehabilitation training on muscle aging. Clinical, functional, and imaging data will be collected from participants with muscle function decline. Multimodal data, including muscle function measurements and clinical assessments, will be integrated to develop and validate an AI-based diagnostic model for sarcopenia. In addition, the effects of rehabilitation training on muscle function and muscle aging-related outcomes will be evaluated. The results of this study are expected to contribute to the development of digital biomarkers and precision rehabilitation strategies for sarcopenia.

Eligibility criteria

Qualifiers

Adults aged 65 years or older

Individuals with reduced muscle function or at risk of sarcopenia

Able to participate in rehabilitation training

Able to understand the study procedures and provide written informed consent

Disqualifiers

Severe cardiovascular, neurological, or musculoskeletal conditions that limit participation in exercise

Severe cognitive impairment

Participation in other clinical trials that may influence study outcomes

Any medical condition judged by the investigator to make participation unsafe

Trial design

Treatments tested in this trial

  • Rehabilitation training

Treatment groups

75 Participants
are divided into 1 treatment group

Locations

This trial has no locations